Cite
HARVARD Citation
Goyal, P. et al. (n.d.). P288 Copd patients with varying severity of airflow limitation achieve highest peak inspiratory flow rate via the breezhaler® inhaler compared to the ellipta® or the handihaler® dry powder inhalers. Thorax. pp. A246-A247. [Online].